There’s a new term to describe the rise of respiratory illnesses this season: “quad-demic.” The “quad” in quad-demic refers ...
During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...
Two new studies, one based on households in southeast Michigan and one involving hospitalized Japanese adults, compare ...
Respiratory syncytial virus (RSV) is known to cause considerable respiratory infection-related morbidity and mortality worldwide.1,2 Estimates published in 2022 from the UK highlight the ...
It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...
A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...
A nationwide surge in flu, COVID-19, RSV and norovirus infections is fueling concerns of a possible virus "quademic." Or is it just winter? The three respiratory viruses plus norovirus ...
Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback